secwatch.observer — SEC 8-K summary
======================================

Issuer:     VivoSim Labs, INC. (VIVS)
CIK:        0001497253
Form:       8-K
Filed at:   2024-05-13T23:59:59+00:00
Accession:  0000950170-24-058805
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Organovo prices $5.25M public offering of common stock and warrants
-------------------------------------------------------------------

- Offering of 6.56M units at $0.80/unit; gross proceeds $5.25M before expenses.
- Each unit includes one share (or pre-funded warrant) and one common warrant exercisable at $0.80 for 5 years.
- Net proceeds ~$4.7M after expenses; expected close May 13, 2024.
- Proceeds to be used for working capital, R&D, clinical trials, and general corporate purposes.
- JonesTrading acted as exclusive placement agent; securities offered under effective S-1 registration statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1497253/000095017024058805/0000950170-24-058805-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1497253/000095017024058805/onvo-20240508.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-058805

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer